Sexually Transmitted Diseases

  • D. Petzoldt
  • F. Allegra
  • F. Camacho-Martinez
  • J. H. Kim
  • A. Alinovi
  • H. Näher
  • P. K. Kohl
  • D. Danielsson
  • Y. T. Kim
  • I. Hernández-Aguado
  • A. Eichmann
  • M. Meurer
  • H. Uno
  • F. C. S. Warner
  • K. T. Schultz
  • L. Gissmann
  • G. Gross
  • G. Elste
  • A. Horváth
Conference paper


Chlamydiae represent a unique group of gram-negative organisms sharing a characteristic intracellular lifestyle. In common with other gram-negative bacteria their surface components, i.e. outer membrane constituents, play a major role in their interaction with their surroundings. Surface antigens appear to modulate the critical events of attachment, uptake, infectivity, toxicity and the host immune responses that contribute to immunity and pathogenesis. The classes of molecules which make up the chlamydial cell envelope are generally similar to those found in other gram-negative bacteria, namely phospholipid, lipid, lipopolysaccharide and protein.


Cervical Intraepithelial Neoplasia Chlamydia Trachomatis Genital Herpes Neisseria Gonorrhoeae Venereal Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Oriel JD, Ridgway GL (1983) Genital infections in men. Br Med Bull 39:133.PubMedGoogle Scholar
  2. 2.
    Märdh PA, Colleen S, Hulmquist B (1972) Chlamydiae in chronic prostatitis. Br Med J 4:361.PubMedCrossRefGoogle Scholar
  3. 3.
    Märdh PA, Colleen S, Sylvan J (1980) Inhibitory effect on the formation of chlamyidial inclusion in McCoy cells by seminal fluid and some of its components. Invest Urol 17:510.PubMedGoogle Scholar
  4. 4.
    Bruce AW, Chadwick P, Willett W et al. (1981) The role of chlamydiae in genitourinary disease. J Urol 126:625.PubMedGoogle Scholar
  5. 5.
    Nilsson S, Johannisson G, Lycke E (1981) Isolation of Chlamydia trachomatis from the urethra and from prostatic fluid in men with signs and symptoms of acute urethritis. Acta Derm Venereol 61:456.PubMedGoogle Scholar
  6. 6.
    Poletti F, Medici MC, Alinovi A et al. (1985) Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis. J Urol 134:691.PubMedGoogle Scholar
  7. 7.
    Berger RE, Alexander ER, Monda GD et al. (1978) Chlamydia trachomatis as a cause of acute “idiopathic” epididymitis. N Engl J Med 298:301.PubMedCrossRefGoogle Scholar
  8. 8.
    Keat A, Thomas BJ, Taylor-Robinson D (1983) Chlamydial infection in the aetiology of arthritis. Br Med Bull 39:168.PubMedGoogle Scholar
  9. 1.
    Bowie WR, Wang S-P, Alexander ER, Floyd J, Forsyth PS, Pollock HM, Shin J-S, Buchanan TM, Holmes KK (1977) Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest 59:735.PubMedCrossRefGoogle Scholar
  10. 2.
    Maiti H, Haye KR (1985) Does detection of chlamydial antibodies by microimmunofluorescence help in managing chlamydial lower genital tract infection in women? Genitourin Med 61:172.PubMedGoogle Scholar
  11. 3.
    Svensson L, Weström L, Ripa KT, Mardh P-A (1981) Acute salpingitis with Chlamydia trachomatis isolated from the fallopian tubes. Clinical cultural and serological findings. Sex Transm Dis 8:51.CrossRefGoogle Scholar
  12. 4.
    Sarov I, Kleinmann D, Holcberg G, Potashnik G, Insler V, Cevenini R, Sarov B (1986) Specific IgG and IgA antibodies to Chlamydia trachomatis in infertile women. Int J Fertil 31(3):193.PubMedGoogle Scholar
  13. 5.
    Puolakkainen M, Vesterinen E, Purola E, Saikku P, Paavonen J (1986) Persistence of chlamydial antibodies after pelvic inflammatory disease. J Clin Microbiol 15:924.Google Scholar
  14. 1.
    Kohl PK, Meyer TF, Petzold D (1985) Gonokokkenoberflächenantigene und ihre Bedeutung für Serotypisierung und Vakzine. Hautarzt 36:320–325.PubMedGoogle Scholar
  15. 2.
    Kellogg DS Jr, Cohen IR, Norins LC, Schroeter AL, Reising G (1968) Neisseria gonorrhoeae. II. Colonial variations and pathogenicity during 35 month in vitro. J Bacteriol 96: 596–60PubMedGoogle Scholar
  16. 3.
    Jephcott AE, Reyn A, Birch-Anderson A (1971) Neisseria gonorrhoeae. III. Demonstration of presumed appendages to cells from different colony types. Acta Path Microbiol Scand (B) 79:437–439.Google Scholar
  17. 4.
    Schoolnik GK, Tai JY, Gotschlich EC (1983) A pilus peptide vaccine for the prevention of gonorrhoeae. Progr Allergy 33:314–331.Google Scholar
  18. 5.
    Mandrell R, Schneider H, Apicella M, Zollinger W, Rice PA, Griffin JMc (1986) Antigenic and physical diversity of Neisseria gonorrheae lipooligosaccharides. Infect Immun 54:63–69.PubMedGoogle Scholar
  19. 6.
    Diaz JL, Heckeis JE (1982) Antigenic variation of outer membrane protein II in colonial variants of Neisseria gonorrhoeae. J Gen Microbiol 128:585–591.PubMedGoogle Scholar
  20. 7.
    Lytton EJ, Blake MS (1986) Isolation and partial characterization of the reduction modifiable protein of Neisseria gonorrhoeae. J Exp Med 164:1749–1759.PubMedCrossRefGoogle Scholar
  21. 8.
    Kohl PK, Buchanan TM (1985) Serotype-specific bactericidal activity of monoclonal antibodies to protein I of Neisseria gonorrhoeae. In: Scholnik GK, Brooks GF, Falkow S, Frasch CE, Knapp JS, McCutchan JA, Morse SA (eds) The pathogenic Neisseriae. American Society for Microbiology, Washington, DC, pp 442–444.Google Scholar
  22. 9.
    Knapp JS, Tarn MR, Nowinski RC, Holmes KK, Sandström EG (1984) Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 150:44–48.PubMedCrossRefGoogle Scholar
  23. 1.
    Catlin BW (1973) J Infect Dis 128:178–194.PubMedCrossRefGoogle Scholar
  24. 2.
    Catlin BW (1978) In: Methods in microbiology. Academic Press, London, pp 345–380.Google Scholar
  25. 3.
    Sandström E, Danielsson D (1980) Acta Path Microbiol Scand B 88:27–38.Google Scholar
  26. 4.
    Maeland JA (1969) Acta Path Microbiol Scand 76:475–483.PubMedCrossRefGoogle Scholar
  27. 5.
    Johnston KH, Holmes KK, Gotschlich EC (1976) J Exp Med 143:741–758.PubMedCrossRefGoogle Scholar
  28. 6.
    Wang S-P, Holmes KK, Knapp JS, Ott S, Kyzer D (1977) J Immunol 119:794–803.Google Scholar
  29. 7.
    Danielsson D (1986) In: Oriel JD, Harris JRW (eds) Recent advances in sexually transmitted diseases. Churchill Livingstone, London, pp 1–21.Google Scholar
  30. 8.
    Sandström EG, Chen KCS, Buchanan TM (1982) Inf Immun 38:462–470.Google Scholar
  31. 9.
    Tarn MR, Buchanan TM, Sandström EG et al. (1982) Inf Immun 36:1042–1053.Google Scholar
  32. 10.
    Knapp JS, Tarn MR, Nowinski RC et al. (1984) J Inf Dis 150:44–48.CrossRefGoogle Scholar
  33. 11.
    Bygdeman S, Danielsson D, Sandström E (1983) Acta Path Microbiol Scand B 91:293–305.Google Scholar
  34. 12.
    Knapp JS, Sandström EG, Holmes KK (1985) In: Schoolnik GK et al. (eds) The pathogenic neisseriae. Am Soc Microbiol, Washington DC, pp 6–12.Google Scholar
  35. 13.
    Whittington WL, Vernon A, Biddle JW et al. (1985) In: Schoolnik GK et al. (eds) The pathogenic neisseriae. Am Soc Microbiol, Washington DC, pp 20–25.Google Scholar
  36. 14.
    Falk ES, Danielsson D, Bjorvatn B et al. (1985) Acta Path Microbiol Scand B 93:91–97.Google Scholar
  37. Bundesamt für Gesundheitswesen: Bulletin No. 43 30.10.1986.Google Scholar
  38. Bundesamt für Gesundheitswesen: Bulletin No. 4 29.01.1987.Google Scholar
  39. Eichmann A (1983) Gonorrhoe in Zürich. Auswertung einer Stichprobe, antibiotische Empfindlichkeit, Penicillinase produzierende Stämme und Auxotypisierung. Habilitationsschrift, Zürich.Google Scholar
  40. Schnyder UW, Eichmann F, Rüdlinger R (1983) Klinik der Syphilis, Änderung der Erscheinungsform. Hautarzt 34:149–150.Google Scholar
  41. 1.
    Meurer M, Braun-Falco O (1986) Serodiagnostik der LAV/HIV-Infektion in der Praxis. Münch Med Wochenschr 128:276–280.Google Scholar
  42. 2.
    Schulte C, Meurer M, Früschl M, Ring J, Gürtler L, Braun-Falco O (1987) Serologische und immunologische Diagnostik bei Personen mit HIV-I-Infektion. DMW (im Druck).Google Scholar
  43. 1.
    Gardner MB, Marx PA (1985) Simian acquired immunodeficiency syndrome. In: Klein G (ed) Advances in viral oncology, vol 5. Raven Press, New York.Google Scholar
  44. 2.
    Tsai C-C, Warner TFCS, Uno H, Giddens WE Jr, Ochs HD (1985) Subcutaneous fibromatosis associated with an acquired immune deficiency syndrome in pig-tailed macaques. Am J Primatol 120:30–37.Google Scholar
  45. 3.
    Kank PJ, Melane MF, King NW et al. (1985) Serologic identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-III. Science 228:1199–1201.CrossRefGoogle Scholar
  46. Gissmann L, Dürst M, Oltersdorf T, von Knebel-Düberitz M (1987) Human papillomaviruses and cervical cancer. In: Steinberg BM, Brandsma JL, Taichman LB (eds) Cancer cells, vol 5. Papilloma Viruses Cold Spring Harbor Laboratory, New York (in press).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • D. Petzoldt
    • 1
  • F. Allegra
    • 2
  • F. Camacho-Martinez
    • 3
  • J. H. Kim
    • 4
  • A. Alinovi
    • 2
  • H. Näher
    • 1
  • P. K. Kohl
    • 1
  • D. Danielsson
    • 5
  • Y. T. Kim
    • 4
  • I. Hernández-Aguado
    • 6
  • A. Eichmann
    • 7
  • M. Meurer
    • 8
  • H. Uno
    • 9
  • F. C. S. Warner
    • 9
  • K. T. Schultz
    • 9
  • L. Gissmann
    • 10
  • G. Gross
    • 11
  • G. Elste
    • 12
  • A. Horváth
    • 13
  1. 1.Department of DermatologyUniversity of HeidelbergHeidelbergGermany
  2. 2.Department of DermatologyUniversity of ParmaParmaItaly
  3. 3.Department of DermatologyUniversity of SevillaSevillaSpain
  4. 4.Department of DermatologyHanyang University College of MedicineSeoulKorea
  5. 5.Department of Clinical Microbiology and ImmunologyÖrebro Medical CentreÖrebroSweden
  6. 6.Department of Community HealthUniversity of Alicante, Alicante Health AuthorityAlicanteSpain
  7. 7.Department of DermatologyUniversity of ZürichZürichSwitzerland
  8. 8.Department of DermatologyUniversity of MunichMunichFR Germany
  9. 9.Wisconsin Regional Primate Research Center and Department of Pathology and Laboratory MedicineUniversity of WisconsinMadisonUSA
  10. 10.German Cancer Research CenterInstitute for Virus ResearchHeidelbergFR Germany
  11. 11.Department of DermatologyUniversity of HamburgHamburgFR Germany
  12. 12.Department of Dermatology and Center for VD-ControlMunicipal Hospital Berlin-BuchBerlinGDR
  13. 13.National Institute of Dermato-VenerologyBudapestHungary

Personalised recommendations